LifeStance Health Group, Inc.
LFST
$7.59
-$0.29-3.68%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 84.18% | 90.33% | 48.82% | 38.39% | 3.64% |
| Total Depreciation and Amortization | -33.96% | -22.97% | -4.76% | 18.33% | 17.63% |
| Total Amortization of Deferred Charges | -21.02% | -18.60% | -20.30% | -22.77% | -14.88% |
| Total Other Non-Cash Items | 176.38% | -19.91% | -21.92% | -14.49% | -80.99% |
| Change in Net Operating Assets | -15.96% | 21.52% | 170.67% | -97.83% | 571.68% |
| Cash from Operations | 271.04% | 189.62% | 10,252.07% | -176.78% | -53.24% |
| Capital Expenditure | 44.80% | 48.44% | 55.88% | 33.96% | -9.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 44.80% | 48.44% | 55.88% | 81.47% | 62.33% |
| Total Debt Issued | 778.73% | -- | -- | -- | 65.00% |
| Total Debt Repaid | -44,168.10% | -12.81% | -24.70% | -24.74% | 90.07% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -260.82% | -7.74% | 35.60% | 60.48% | -462.67% |
| Cash from Financing | -113.16% | -9.52% | -106.14% | 50.27% | 143.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 43.45% | 142.29% | 231.69% | 27.16% | 98.08% |
